Literature DB >> 32666697

The effect of induced membranes combined with enhanced bone marrow and 3D PLA-HA on repairing long bone defects in vivo.

Zhiqing Liu1, Yuwei Ge1, Linyuan Zhang1, Yueting Wang1, Cheng Guo2, Kai Feng1, Shengbing Yang1, Zanjing Zhai1, Yingjun Chi3, Jie Zhao1, Fengxiang Liu1.   

Abstract

The repair of large bone defects has always been a challenge, especially with respect to regeneration capacity and autogenous bone availability. To address this problem, we fabricated a 3D-printed polylactic acid (PLA) and hydroxyapatite (HA) scaffold (3D-printed PLA-HA, providing scaffold) loaded with enhanced bone marrow (eBM, providing seed cells) combined with induced membrane (IM, providing grow factors) to repair large radial defects in rabbits. in vitro assays, we demonstrated that 3D-printed PLA-HA had excellent biocompatibility, as shown by co-culturing with mesenchymal stem cells (MSCs); eBM-derived MSCs exhibited considerable differentiation potential, as shown in trilineage differentiation assays. To investigate bone formation efficacy in vivo, the rabbit radial long bone defect model was established. In the first stage, polymethylmethacrylate (PMMA) was inserted into the bone defect to stimulate the formation of IM; in the second stage, iliac crest bone graft (ICBG) with IM, PLA-HA alone with the removal of IM, PLA-HA with IM, and PLA-HA in conjunction with IM and eBM were sequentially applied to repair the long bone defect. At 8, 12, and 16 weeks, X-ray plain radiography, microcomputed tomography, and histological analysis were performed to evaluate the efficacy of bone repair and bone regeneration in each group. We found that IM combined with PLA-HA and eBM prominently enhanced bone repair and reconstruction, equivalent to that of IM/ICBG. Taken together, the data suggest that PLA-HA loaded with eBM combined with IM can be an alternative to IM with bone autografts for the treatment of large bone defects.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  3D PLA-HA; MSC; bone tissue engineering; enhanced bone marrow; induced membrane technique; long bone defects

Year:  2020        PMID: 32666697     DOI: 10.1002/term.3106

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  6 in total

1.  The healing of bone defects by cell-free and stem cell-seeded 3D-printed PLA tissue-engineered scaffolds.

Authors:  Marjan Bahraminasab; Athar Talebi; Nesa Doostmohammadi; Samaneh Arab; Ali Ghanbari; Sam Zarbakhsh
Journal:  J Orthop Surg Res       Date:  2022-06-20       Impact factor: 2.677

2.  The effect of enhanced bone marrow in conjunction with 3D-printed PLA-HA in the repair of critical-sized bone defects in a rabbit model.

Authors:  Zhiqing Liu; Wenxiang Chu; Linyuan Zhang; Yueting Wang; Zanjing Zhai; Fengxiang Liu
Journal:  Ann Transl Med       Date:  2021-07

Review 3.  Mesenchymal Stem Cells, Bioactive Factors, and Scaffolds in Bone Repair: From Research Perspectives to Clinical Practice.

Authors:  Sandra Stamnitz; Aleksandra Klimczak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

4.  The induced membrane technique in animal models: a systematic review.

Authors:  Hening Sun; Charles Godbout; Kalter Hali; Jovana Momic; Emil H Schemitsch; Aaron Nauth
Journal:  OTA Int       Date:  2022-03-10

5.  Three-dimensional printed polylactic acid and hydroxyapatite composite scaffold with urine-derived stem cells as a treatment for bone defects.

Authors:  Xiang Zhang; Jia-Lei Chen; Fei Xing; Xin Duan
Journal:  J Mater Sci Mater Med       Date:  2022-10-03       Impact factor: 4.727

Review 6.  Poly(lactic Acid): A Versatile Biobased Polymer for the Future with Multifunctional Properties-From Monomer Synthesis, Polymerization Techniques and Molecular Weight Increase to PLA Applications.

Authors:  Evangelia Balla; Vasileios Daniilidis; Georgia Karlioti; Theocharis Kalamas; Myrika Stefanidou; Nikolaos D Bikiaris; Antonios Vlachopoulos; Ioanna Koumentakou; Dimitrios N Bikiaris
Journal:  Polymers (Basel)       Date:  2021-05-31       Impact factor: 4.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.